Journals / Turkish Journal of Gastroenterology / 2015 / Cilt: 26 - Sayı: 2

Low-dose ramosetron accelerates gastric emptying in the early phase: A crossover study in healthy volunteers using a continuous real-time 13C breath test (BreathID System)

Pages
123–127
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: This study showed that ramosetron pre-treatment enhances the early gastric emptying of liquid nutrients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aims: The aim of this study was to determine the correlation between low-dose ramosetron pretreatment and gastric emptying using a novel, non-invasive technique for measuring gastric emptying, namely, the continuous real-time 13C breath test (BreathID system: Exalenz Bioscience Ltd., Israel).Materials and Methods: Twelve healthy male volunteers participated in this randomized two-way crossover study.
📊
Key Findings & Data:The subjects fasted overnight and were randomly assigned to receive the test meal (200 kcal per 200 mL) after an hour pre-treatment with 5 µg ramosetron or the test meal alone.
💡
Conclusion & Impact:Conclusion: This study showed that ramosetron pre-treatment enhances the early gastric emptying of liquid nutrients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background/Aims: The aim of this study was to determine the correlation between low-dose ramosetron pretreatment and gastric emptying using a novel, non-invasive technique for measuring gastric emptying, namely, the continuous real-time 13C breath test (BreathID system: Exalenz Bioscience Ltd., Israel).Materials and Methods: Twelve healthy male volunteers participated in this randomized two-way crossover study. The subjects fasted overnight and were randomly assigned to receive the test meal (200 kcal per 200 mL) after an hour pre-treatment with 5 µg ramosetron or the test meal alone. Gastric emptying was monitored for 4 hours after administration of the test meal with the 13C-acetic acid breath test performed continuously using the BreathID system. Using Oridion Research Software (? version), T 1/2, T lag, GEC and the regression-estimated constants (? and ?) were calculated. The differences in the parameters measured at two time-points were analyzed using Wilcoxon's signed-rank test. Results: There was a significant difference in the calculated parameter ?. No significant differences in the calculated parameters T 1/2, T lag, GEC or ? were observed between the test meal with ramosetron group and the test meal alone group. Conclusion: This study showed that ramosetron pre-treatment enhances the early gastric emptying of liquid nutrients.

🔖

Cite This Article

INOUE, S., SAKAMOTO, Y., SEKİNO, Y., NONAKA, T., IİDA, H., ENDO, H., KOİDE, T., TAKAHASHİ, H., MAEDA, S., NAKAJIMA, A., GOTOH, E., INAMORİ, M. (2015). Low-dose ramosetron accelerates gastric emptying in the early phase: A crossover study in healthy volunteers using a continuous real-time 13C breath test (BreathID System). Turkish Journal of Gastroenterology, Cilt: 26 - Sayı: 2, 123–127. https://ajindex.com/articles/406411

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Pentilla A. Histochemical reactions of enterochromaffin cells and the 5-hydroxytryptamine content of the mammalian duodenum. Acta Phvsiol Scand 1966; 281: 1-77.
  2. Buchheit KH, Engel G, Muschler E. and Richardson BP. Study of the contractile effect of 5-hydroxy tryptamine (5-HT) in the iso- lated longitudinal muscle strip from guinea-pig ileum. Naunyn Schmiedebergs Arch Pharmacol 1985; 32: 36-41. [CrossRef] Richardson BP, Engel G. The pharmacology and function of 5-HT3 receptors. Trends Neurosci 1986; 9: 424-8. [CrossRef] Dumuis A, Sebben M, Bockaert J. The gastrointestinal prokinetic benzamide derivatives are agonists a t the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neu- rons. Naunyn Schmiedebergs Arch. Pharmacol 1989; 340: 403-10. [CrossRef] Hendriks R, Bornstein JC, Furnness JB. Evidence for two types of 5-hydroxytryptamine receptor on secretomot or neurons of the guinea-pig ileum. Naunyn Schmiedebergs Arch Pharmacol 1989; 339: 409-14. [CrossRef] Buchheit KH, Costall B, Engel G, Gunning SJ, Naylor RJ, Richard- son BP. 5-Hydroxytryptamine receptor antagonism by metoclo- pramide and ICS 205-930 in the guinea-pig leads to enhance- ment of constractions of stomach muscle strips induced by electrical field stimulation and facilitation of gastric emptying in vivo. J Pharm Pharmacol 1985; 37: 664-7. [CrossRef] Gidda JS, Evans DC, Prime P, Shenck K, Cohen ML. Role of 5-HT3 receptor antagonists in gastrointestinal motility. Gastroenterol- ogy 1988; 95: 867. Gullikson GW, Loeffler RF, Bianchi RG, Perkins WE, Bauer RF. Relation- ship of 5-HT3 receptor antagonist activity to gastrointestinal proki- netic activity in conscious dogs. Gastroenterology 1988; 95: 869. Costall B, Gunning SJ, Naylor RJ, Tyers MB. The effect of GR38032F, a novel 5-HT3 receptor antagonist on gastric emptying in the guinea-pig. Br. J. Pharmacol. 1987; 91: 263-4. [CrossRef] Fozard JR. The development and early clinical evaluation of se- lective 5-HT3 receptor antagonists. In The Peripheral Actions of 5-Hydroxytryptamine, Edited by Fozard JR. Oxford: Oxford Univer- sity Press; 1989.p.374-6.
  3. Andrews PLR, Rapeport WG, Sanger GJ. Neuropharmacology of emesis induced by anti-cancer therapy. Trends Pharmacol Sci 1988; 9: 334-41. [CrossRef] Bermudez J, Boyle EA, Miner WD, Sanger GJ. The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694. Br J Cancer 1988; 58: 644-50. [CrossRef] King FD, Sanger GJ. 5-HT3 receptor antagonists. Drugs Future